Granulocyte-Colony Stimulating Factor as Treatment Option in Patients with Recurrent Miscarriage


In 1–5 % of patients during childbearing years recurrent miscarriages (RM) occur. There are established risk factors like anatomical, endocrine and hemostatic disorders as well as immunological changes in the maternal immune system. Nevertheless, further elucidation of the pathogenesis remains a matter of debate. In addition, there are no standardized… (More)
DOI: 10.1007/s00005-012-0212-z


3 Figures and Tables